179 related articles for article (PubMed ID: 4380581)
21. [Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Schuppli R
Minerva Med; 1970 Jul; 61(55):3070-3. PubMed ID: 5427679
[No Abstract] [Full Text] [Related]
22. Childhood systemic lupus erythematosus, dermatomyositis, scleroderma, and systemic vasculitis.
Ilowite NT
Curr Opin Rheumatol; 1993 Sep; 5(5):644-50. PubMed ID: 8104454
[TBL] [Abstract][Full Text] [Related]
23. [Immunosuppressive agents].
Stüttgen G
Arch Dermatol Forsch; 1972; 244():406-9. PubMed ID: 4405404
[No Abstract] [Full Text] [Related]
24. [Hyperergic collagenoses. Clinical aspects, differential diagnosis and therapy (author's transl)].
Alexander M; Kampf D
MMW Munch Med Wochenschr; 1977 Oct; 119(42):1357-64. PubMed ID: 22036
[TBL] [Abstract][Full Text] [Related]
25. [Cardiac manifestations of the so-called collagen diseases (lupus erythematosus disseminated, periarteritis nodosa, scleroderma, dermatomyositis)].
ABASTADO M
Bull Mem Soc Med Hop Paris; 1962; 113():1229-44. PubMed ID: 14010534
[No Abstract] [Full Text] [Related]
26. [Side effects of antibiotics in rheumatic diseases].
Matveĭkov GP; Pshonik SS; Poliakova TI; Aronin TsS
Antibiotiki; 1977 Sep; 22(9):813-6. PubMed ID: 20835
[TBL] [Abstract][Full Text] [Related]
27. Clinical cutaneous lesions in the collagen diseases.
Brodkin RH
J Med Soc N J; 1969 Nov; 66(11):625-8. PubMed ID: 4390716
[No Abstract] [Full Text] [Related]
28. [Drug therapy in collagen diseases].
Brühl W
Wiad Lek; 1971 Jul; 24(13):1279-83. PubMed ID: 4256585
[No Abstract] [Full Text] [Related]
29. Pharmacodynamic observations on metronidazole therapy. Side effects in endocrine, metabolic and auto-immune disorders. 3. Anti-ischemic and anti-inflammatory action in peripheral vascular disorders.
Taylor JA
Proc West Pharmacol Soc; 1966; 9():37-9. PubMed ID: 4381145
[No Abstract] [Full Text] [Related]
30. [Collagen diseases. On clinical aspects and theapy of disseminated lupus erythematosus, progressive scleroderma and dermatomyositis].
Günther R; Boros A
Hippokrates; 1969 Aug; 40(16):626-34. PubMed ID: 5810176
[No Abstract] [Full Text] [Related]
31. [Significance of immunofluorescence in dermatology].
Holubar K
Z Haut Geschlechtskr; 1970 Feb; 45(3):113-20. PubMed ID: 4911829
[No Abstract] [Full Text] [Related]
32. [Autoagression and immunosuppression in dermatology. II. Autoagression dermatoses and their detection].
Novotný F
Cesk Dermatol; 1973 Jan; 48(1):37-42. PubMed ID: 4569063
[No Abstract] [Full Text] [Related]
33. [Clinical study with a new phenylbutazone preparation in rheumatology].
Marmont A; Rossi F
Clin Ter; 1972 Oct; 63(1):17-51. PubMed ID: 4566104
[No Abstract] [Full Text] [Related]
34. [ON THE DIAGNOSIS, DIFFERENTIAL DIAGNOSIS AND THERAPY OF THE SO-CALLED COLLAGENOSES IN CHILDHOOD].
ALTHOFF H
Med Welt; 1964 Apr; 15():838-41. PubMed ID: 14194501
[No Abstract] [Full Text] [Related]
35. [Therapy of chronic lupus erythematosus (late results)].
Levkovskiĭ NM
Vestn Dermatol Venerol; 1978 Oct; (10):68-71. PubMed ID: 360672
[No Abstract] [Full Text] [Related]
36. [SLE (and other collagen diseases)].
Oshima Y; Hazama T
Naika; 1965 Aug; 16(2):306-8. PubMed ID: 5885251
[No Abstract] [Full Text] [Related]
37. Polyarteritis nodosa developing after discoid lupus erythematosus.
Letellier E; Longhurst H; Diaz-Cano SJ; D'Cruz D
Clin Exp Rheumatol; 2001; 19(6):738-9. PubMed ID: 11791651
[TBL] [Abstract][Full Text] [Related]
38. Current trends in dermatology.
Pirozzi DJ
J Med Assoc Ga; 1980 May; 69(5):345-9. PubMed ID: 7373172
[No Abstract] [Full Text] [Related]
39. [Treatment of collagenoses with cytostatic agents].
Klabusay L
Vnitr Lek; 1980 Oct; 26(10):941-6. PubMed ID: 6110279
[No Abstract] [Full Text] [Related]
40. [Immunosuppressive treatment in immunopathologic disorders].
Salmon J; Lambert PH
J Belge Rhumatol Med Phys; 1967; 22(4):267-75. PubMed ID: 4390266
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
